Related Experiment Video
Updated: Jun 6, 2026
08:11
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population
1Department of Medicine and Geriatrics, Kwong Wah Hospital, 25 Waterloo Road, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|December 8, 2010
Summary
Amiodarone can cause thyroid dysfunction in 28% of patients. Early thyroid-stimulating hormone monitoring is crucial, especially for those with elevated levels, to manage these common conditions effectively.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Amiodarone is an effective antiarrhythmic drug.
- Thyroid dysfunction is a known side effect of amiodarone therapy.
- Understanding the incidence and characteristics of amiodarone-induced thyroid dysfunction is important for patient management.
Purpose of the Study:
- To determine the frequency, risk factors, clinical features, and management of amiodarone-induced thyroid dysfunctions.
- To identify predictors of amiodarone-induced hypothyroidism.
- To describe the clinical presentation and outcomes of amiodarone-induced thyrotoxicosis.
Main Methods:
- Retrospective study design.
- Inclusion of patients prescribed amiodarone for at least six months.
- Data collection from a regional hospital in Hong Kong.
Main Results:
- A total of 390 patients were studied.
- Hypothyroidism developed in 22% and thyrotoxicosis in 6% of patients.
- Elevated baseline thyroid-stimulating hormone (TSH) levels predicted hypothyroidism, while thyrotoxicosis occurred in younger patients with atypical symptoms.
Conclusions:
- Amiodarone-induced thyroid dysfunction is common.
- Regular biochemical monitoring of thyroid function is recommended, particularly for patients with elevated baseline TSH.
- Amiodarone-induced thyrotoxicosis is generally benign and responds well to treatment.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...